Search Results - "Alimova, Irina N."

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro by Alimova, Irina N., Liu, Bolin, Fan, Zeying, Edgerton, Susan M., Dillon, Thomas, Lind, Stuart E., Thor, Ann D.

    Published in Cell cycle (Georgetown, Tex.) (15-03-2009)
    “…The anti-diabetic drug metformin reduces human cancer incidence and improves the survival of cancer patients, including those with breast cancer. We studied…”
    Get full text
    Journal Article
  2. 2

    Metformin induces unique biological and molecular responses in triple negative breast cancer cells by Liu, Bolin, Fan, Zeying, Edgerton, Susan M., Deng, Xin-Sheng, Alimova, Irina N., Lind, Stuart E., Thor, Ann D.

    Published in Cell cycle (Georgetown, Tex.) (01-07-2009)
    “…Triple negative (TN) breast cancer is more frequent in women who are obese or have type II diabetes, as well as young Women of Color. These cancers do not…”
    Get full text
    Journal Article
  3. 3

    Loss of CAK phosphorylation of RARα mediates transcriptional control of retinoid-induced cancer cell differentiation by Wang, Anxun, Alimova, Irina N, Luo, Peihua, Jong, Ambrose, Triche, Timothy J, Wu, Lingtao

    Published in The FASEB journal (01-03-2010)
    “…Although the role of the classic retinoic acid (RA)-induced genomic pathway in cancer cell differentiation is well recognized, the underlying mechanisms remain…”
    Get full text
    Journal Article
  4. 4

    The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER‐2/neu transgenic mice by Anisimov, Vladimir N., Alimova, Irina N., Baturin, Dmitri A., Popovich, Irina G., Zabezhinski, Mark A., Manton, Kenneth G., Semenchenko, Anna V., Yashin, Anatoly I.

    Published in International journal of cancer (20-01-2003)
    “…The effect of various regimens of treatment with melatonin on the development of mammary tumors in HER2/neu transgenic mice was investigated. Female HER‐2/neu…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Dose-dependent effect of melatonin on life span and spontaneous tumor incidence in female SHR mice by Anisimov, Vladimir N, Alimova, Irina N, Baturin, Dmitri A, Popovich, Irina G, Zabezhinski, Mark A, Rosenfeld, Svetlana V, Manton, Kenneth G, Semenchenko, Anna V, Yashin, Anatoli I

    Published in Experimental gerontology (01-04-2003)
    “…From the age of 3 months until their natural death, female Swiss-derived SHR mice were given melatonin with their drinking water (2 or 20 mg/l) for 5…”
    Get full text
    Journal Article
  7. 7

    Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER‐2/neu transgenic mice by Anisimov, Vladimir N., Khavinson, Vladimir KH, Provinciali, Mauro, Alimova, Irina N., Baturin, Dmitri A., Popovich, Irina G., Zabezhinski, Mark A., Imyanitov, Eugeni N., Mancini, Romina, Franceschi, Claudio

    Published in International journal of cancer (01-09-2002)
    “…Female FVB/N HER‐2/neu transgenic mice from the age of 2 months were subcutaneously injected with saline, the peptide Epitalon® (Ala‐Glu‐Asp‐Gly) or with the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Number of pregnancies and ovariectomy modify mammary carcinoma development in transgenic HER-2/neu female mice by Anisimov, Vladimir N., Popovich, Irina G., Alimova, Irina N., Zabezhinski, Mark A., Semenchenko, Anna V., Yashin, Anatoli I.

    Published in Cancer letters (10-04-2003)
    “…We studied effect of pregnancy and ovariectomy on the development of mammary tumors in homozygous female HER-2/neutransgenic mice. The mean life span of…”
    Get full text
    Journal Article
  10. 10

    Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice by ANISIMOV, Vladimir N, KHAVINSON, Vladimir Kh, POPOVICH, Irina G, ZABEZHINSKI, Mark A, ALIMOVA, Irina N, ROSENFELD, Svetlana V, ZAVARZINA, Natalia Yu, SEMENCHENKO, Anna V, YASHIN, Anatoli I

    Published in Biogerontology (Dordrecht) (01-01-2003)
    “…From the age of 3 months until their natural deaths, female outbred Swiss-derived SHR mice were subcutaneously injected on 5 consecutive days every month with…”
    Get full text
    Journal Article
  11. 11

    A clinical case of a new coronavirus infection (COVID-19) with fatal outcome in a patient with tuberous sclerosis by Kvasova, O.G., Tomashevskaya, Yu.A., Alimova, I.N., Klimova, E.A., Sadovnikova, E.A.

    “…Background. Tuberous sclerosis (TS) is a genetically determined disease with an autosomal dominant type of inheritance. In the population, TS occurs with a…”
    Get full text
    Journal Article
  12. 12

    Abstract 3446: Inhibition of EZH2 suppresses medulloblastoma cell growth by Alimova, Irina N., Venkataraman, Sujatha, Harris, Peter, Vibhakar, Rajeev

    Published in Cancer research (Chicago, Ill.) (15-04-2011)
    “…EZH2 (enhancer of zeste homologue2) is a polycomb group protein that mediates repression of gene transcription through its Histone 3 Lysine 27methyltransferase…”
    Get full text
    Journal Article
  13. 13

    Abstract 2483: Inhibition of the polycomb group gene EZH2 suppresses growth and radiosensitizes ATRT cells by promoting senescence and inhibiting the CycinD-E2F1 axis by Alimova, Irina N., Venkataraman, Sujatha, Harris, Peter, Marquez, Victor E., Birks, Diane, Foreman, Nicholas K., Vibhakar, Rajeev

    Published in Cancer research (Chicago, Ill.) (15-04-2012)
    “…Overexpression of the polycomb group gene Enhancer of Zeste 2 (EZH2) occurs in many tumors including prostate cancer, breast cancer and brain tumors such as…”
    Get full text
    Journal Article
  14. 14

    Loss of CAK phosphorylation of RARa mediates transcriptional control of retinoid‐induced cancer cell differentiation by Wang, Anxun, Alimova, Irina N., Luo, Peihua, Jgon, Ambrose, Triche, Timothy J., Wu, Lingtao

    Published in The FASEB journal (01-03-2010)
    “…Although the role of the classic retinoic acid (RA)‐induced genomic pathway in cancer cell differentiation is well recognized, the underlying mechanisms remain…”
    Get full text
    Journal Article
  15. 15

    Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation by Wang, Anxun, Alimova, Irina N, Luo, Peihua, Jong, Ambrose, Triche, Timothy J, Wu, Lingtao

    Published in The FASEB journal (01-03-2010)
    “…Although the role of the classic retinoic acid (RA)-induced genomic pathway in cancer cell differentiation is well recognized, the underlying mechanisms remain…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18